Mairs RJ - Search Results

1

Assessment in vitro of a novel therapeutic strategy for glioma, combining herpes simplex virus HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy.

Quigg M, Mairs RJ, Brown SM, Harland J, Dunn P, Rampling R, Livingstone A, Wilson L, Boyd M. Quigg M, et al. Among authors: mairs rj. Med Chem. 2005 Sep;1(5):423-9. doi: 10.2174/1573406054864124. Med Chem. 2005. PMID: 16787326

2

Application of targeted radiotherapy/gene therapy to bladder cancer cell lines.

Fullerton NE, Mairs RJ, Kirk D, Keith WN, Carruthers R, McCluskey AG, Brown M, Wilson L, Boyd M. Fullerton NE, et al. Among authors: mairs rj. Eur Urol. 2005 Feb;47(2):250-6. doi: 10.1016/j.eururo.2004.09.009. Eur Urol. 2005. PMID: 15661422

3

Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.

Fullerton NE, Boyd M, Ross SC, Pimlott SL, Babich J, Kirk D, Zalutsky MR, Mairs RJ. Fullerton NE, et al. Among authors: mairs rj. Med Chem. 2005 Nov;1(6):611-8. doi: 10.2174/157340605774598090. Med Chem. 2005. PMID: 16787344

4

Applications of gene transfer to targeted radiotherapy.

Mairs RJ, Cunningham SH, Boyd M, Carlin S. Mairs RJ, et al. Curr Pharm Des. 2000 Sep;6(14):1419-32. doi: 10.2174/1381612003399194. Curr Pharm Des. 2000. PMID: 10903401 Review.

5

Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill.

Boyd M, Mairs RJ, Mairs SC, Wilson L, Livingstone A, Cunningham SH, Brown MM, Quigg M, Keith WN. Boyd M, et al. Among authors: mairs rj, mairs sc. Oncogene. 2001 Nov 22;20(53):7804-8. doi: 10.1038/sj.onc.1204955. Oncogene. 2001. PMID: 11753659

6

Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate.

Fullerton NE, Boyd M, Mairs RJ, Keith WN, Alderwish O, Brown MM, Livingstone A, Kirk D. Fullerton NE, et al. Among authors: mairs rj. Prostate Cancer Prostatic Dis. 2004;7(4):355-63. doi: 10.1038/sj.pcan.4500760. Prostate Cancer Prostatic Dis. 2004. PMID: 15477875

7

An efficient targeted radiotherapy/gene therapy strategy utilising human telomerase promoters and radioastatine and harnessing radiation-mediated bystander effects.

Boyd M, Mairs RJ, Keith WN, Ross SC, Welsh P, Akabani G, Owens J, Vaidyanathan G, Carruthers R, Dorrens J, Zalutsky MR. Boyd M, et al. Among authors: mairs rj. J Gene Med. 2004 Aug;6(8):937-47. doi: 10.1002/jgm.578. J Gene Med. 2004. PMID: 15293352

8

Gene manipulation to enhance MIBG-targeted radionuclide therapy.

Mairs RJ, Fullerton NE, Cosimo E, Boyd M. Mairs RJ, et al. Nucl Med Biol. 2005 Oct;32(7):749-53. doi: 10.1016/j.nucmedbio.2005.03.011. Nucl Med Biol. 2005. PMID: 16243651 Review.

9

A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivo.

Mairs RJ, Ross SC, McCluskey AG, Boyd M. Mairs RJ, et al. J Nucl Med. 2007 Sep;48(9):1519-26. doi: 10.2967/jnumed.107.042226. Epub 2007 Aug 17. J Nucl Med. 2007. PMID: 17704246 Free article.

10

Radiation quality-dependent bystander effects elicited by targeted radionuclides.

Boyd M, Sorensen A, McCluskey AG, Mairs RJ. Boyd M, et al. Among authors: mairs rj. J Pharm Pharmacol. 2008 Aug;60(8):951-8. doi: 10.1211/jpp.60.8.0002. J Pharm Pharmacol. 2008. PMID: 18644188 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters